DE60033649D1 - Verbindungen und therapeutische methoden - Google Patents

Verbindungen und therapeutische methoden

Info

Publication number: DE60033649D1
Authority: DE; Germany
Prior art keywords: compounds; therapeutic methods; treatment; diseases; methods
Prior art date: 1999-05-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60033649T

Other languages

English (en)

Inventor

Rodney W Rickards

Geoffrey D Smith

Kiaran Kirk

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Australian National University

Original Assignee

Australian National University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-14

Filing date

2000-05-12

Publication date

2007-04-12

1999-05-14 Priority claimed from AUPQ0373A external-priority patent/AUPQ037399A0/en

1999-05-21 Priority claimed from AUPQ0506A external-priority patent/AUPQ050699A0/en

2000-05-12 Application filed by Australian National University filed Critical Australian National University

2007-04-12 Application granted granted Critical

2007-04-12 Publication of DE60033649D1 publication Critical patent/DE60033649D1/de

2020-05-13 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

150000001875 compounds Chemical class 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title 1
ZXCZNUMWHATQSR-UHFFFAOYSA-N 10,20-diazapentacyclo[11.8.0.03,11.04,9.014,19]henicosa-1(13),3,5,7,9,11,14,16,18,20-decaene Chemical class C1=NC2=CC=CC=C2C2=C1CC1=C(C=CC=C3)C3=NC1=C2 ZXCZNUMWHATQSR-UHFFFAOYSA-N 0.000 abstract 1
241000224482 Apicomplexa Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
208000030852 Parasitic disease Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

DE60033649T 1999-05-14 2000-05-12 Verbindungen und therapeutische methoden Expired - Lifetime DE60033649D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
AUPQ0373A AUPQ037399A0 (en)	1999-05-14	1999-05-14	Novel compounds and therapeutic methods
AUPQ0506A AUPQ050699A0 (en)	1999-05-21	1999-05-21	Novel compounds and therapeutic methods-ii
PCT/AU2000/000458 WO2000069856A1 (en)	1999-05-14	2000-05-12	Compounds and therapeutic methods

Publications (1)

Publication Number	Publication Date
DE60033649D1 true DE60033649D1 (de)	2007-04-12

Family

ID=25646057

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60033649T Expired - Lifetime DE60033649D1 (de)	1999-05-14	2000-05-12	Verbindungen und therapeutische methoden

Country Status (7)

Country	Link
US (1)	US6632822B1 (de)
EP (1)	EP1178988B1 (de)
JP (1)	JP2002544275A (de)
AT (1)	ATE355288T1 (de)
CA (1)	CA2372032A1 (de)
DE (1)	DE60033649D1 (de)
WO (1)	WO2000069856A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8962023B2 (en)	2004-09-28	2015-02-24	Atrium Medical Corporation	UV cured gel and method of making
US9000040B2 (en)	2004-09-28	2015-04-07	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US9012506B2 (en)	2004-09-28	2015-04-21	Atrium Medical Corporation	Cross-linked fatty acid-based biomaterials
US9801982B2 (en)	2004-09-28	2017-10-31	Atrium Medical Corporation	Implantable barrier device
US8312836B2 (en)	2004-09-28	2012-11-20	Atrium Medical Corporation	Method and apparatus for application of a fresh coating on a medical device
WO2006036967A1 (en) *	2004-09-28	2006-04-06	Atrium Medical Corporation	Solubilizing a drug for use in a coating
US8367099B2 (en)	2004-09-28	2013-02-05	Atrium Medical Corporation	Perforated fatty acid films
US9427423B2 (en)	2009-03-10	2016-08-30	Atrium Medical Corporation	Fatty-acid based particles
US9278161B2 (en)	2005-09-28	2016-03-08	Atrium Medical Corporation	Tissue-separating fatty acid adhesion barrier
CA2626030A1 (en)	2005-10-15	2007-04-26	Atrium Medical Corporation	Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008057344A2 (en)	2006-11-06	2008-05-15	Atrium Medical Corporation	Coated surgical mesh
US9492596B2 (en)	2006-11-06	2016-11-15	Atrium Medical Corporation	Barrier layer with underlying medical device and one or more reinforcing support structures
CA2764653C (en)	2009-06-10	2018-01-02	Chugai Seiyaku Kabushiki Kaisha	Tetracyclic compounds
US20110038910A1 (en)	2009-08-11	2011-02-17	Atrium Medical Corporation	Anti-infective antimicrobial-containing biomaterials
WO2012009707A2 (en)	2010-07-16	2012-01-19	Atrium Medical Corporation	Composition and methods for altering the rate of hydrolysis of cured oil-based materials
EP2606886B1 (de)	2010-08-20	2020-01-08	Chugai Seiyaku Kabushiki Kaisha	Zusammensetzung umfassend eine tetrazyklische verbindung
US9867880B2 (en)	2012-06-13	2018-01-16	Atrium Medical Corporation	Cured oil-hydrogel biomaterial compositions for controlled drug delivery
CA3077553C (en)	2012-09-25	2022-08-02	Chugai Seiyaku Kabushiki Kaisha	Ret inhibitor
AU2015250574B2 (en)	2014-04-25	2020-07-16	Chugai Seiyaku Kabushiki Kaisha	Preparation containing tetracyclic compound at high dose
CA2946268A1 (en)	2014-04-25	2015-10-29	Chugai Seiyaku Kabushiki Kaisha	Crystal of tetracyclic compound
TWI718102B (zh)	2014-08-08	2021-02-11	日商中外製藥股份有限公司	４環性化合物的非晶質體
US11077093B2 (en)	2015-01-16	2021-08-03	Chugai Seiyaku Kabushiki Kaisha	Combination drug
AR116113A1 (es)	2018-09-04	2021-03-31	Chugai Pharmaceutical Co Ltd	Método para fabricar un compuesto tetracíclico

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU743899B2 (en)	1997-07-18	2002-02-07	Georgetown University	Bicyclic metabotropic glutamate receptor ligands
AU1153601A (en)	1999-10-29	2001-05-08	Merck Sharp & Dohme Limited	Method to treat pain utilizing benzimidazole NMDA NR2B antagonists

2000
- 2000-05-12 CA CA002372032A patent/CA2372032A1/en not_active Abandoned
- 2000-05-12 JP JP2000618273A patent/JP2002544275A/ja not_active Withdrawn
- 2000-05-12 DE DE60033649T patent/DE60033649D1/de not_active Expired - Lifetime
- 2000-05-12 US US09/980,506 patent/US6632822B1/en not_active Expired - Fee Related
- 2000-05-12 AT AT00926538T patent/ATE355288T1/de not_active IP Right Cessation
- 2000-05-12 EP EP00926538A patent/EP1178988B1/de not_active Expired - Lifetime
- 2000-05-12 WO PCT/AU2000/000458 patent/WO2000069856A1/en active IP Right Grant

Also Published As

Publication number	Publication date
EP1178988A4 (de)	2004-10-06
CA2372032A1 (en)	2000-11-23
EP1178988A1 (de)	2002-02-13
JP2002544275A (ja)	2002-12-24
EP1178988B1 (de)	2007-02-28
US6632822B1 (en)	2003-10-14
WO2000069856A1 (en)	2000-11-23
ATE355288T1 (de)	2006-03-15

Similar Documents

Publication	Publication Date	Title
ATE355288T1 (de)	2006-03-15	Verbindungen und therapeutische methoden
WO2003096990A3 (en)	2004-02-26	Protein cages for the delivery of medical imaging and therapy
DE60029799D1 (de)	2006-09-14	Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
ATE339406T1 (de)	2006-10-15	Chinazoline verbindungen als heilmittel
DE60038183D1 (de)	2008-04-10	Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
ME00513B (me)	2011-10-10	Azabicikloalkani kao modulatori ccr5
TR199903331T2 (xx)	2000-06-21	Farnesil protein transferas engelleyicileri.
HK1069316A1 (en)	2005-05-20	Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
MXPA02006029A (es)	2004-08-23	Lipopeptidos novedosos como agentes antibacterianos.
MXPA02006030A (es)	2004-08-23	Lipopeptidos como agentes antibacterianos.
ATE355374T1 (de)	2006-03-15	Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
IL176007A0 (en)	2006-10-05	Antibodies specific to c35 and pharmaceutical compositions containing the same
HK1021699A1 (en)	2000-06-30	Pentafluorobenzenesulfonamides and analogs.
AU3304400A (en)	2000-10-09	Tetrahydropyran derivatives and their use as therapeutic agents
IS6558A (is)	2002-09-20	Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
YU13301A (sh)	2005-06-10	Muskarinski agonisti i antagonisti
ES2144054T3 (es)	2000-06-01	Complejos de tri(platino).
SE0003476D0 (sv)	2000-09-28	Compounds
TR200103638T2 (tr)	2002-04-22	IL-8 Reseptör antagonistleri
DE69612056D1 (de)	2001-04-19	Terpenderivate (sarcodictyine) als antikrebsmittel
MXPA06007007A (es)	2007-06-08	Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE69514100T2 (de)	2000-05-25	Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel
ATE306283T1 (de)	2005-10-15	Biotin-derivate und ihre konjugaten mit chelatierungsmitteln
ATE404550T1 (de)	2008-08-15	Chemische verbindungen
AU7079300A (en)	2001-03-26	Compositions and methods for the treatment of immune related diseases

Legal Events

Date	Code	Title	Description
2007-12-20	8332	No legal effect for de